Katina D. Hulme

Katina D. Hulme

Auto-generated profile, based on publicly available information

Katina D. Hulme

Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2017 in Frontiers in Microbiology
Verified
Journal Article
Open access
KHKatina D. Hulme
Katina D. Hulme
LGLinda Gallo
Linda Gallo
Kirsty ShortKirsty Short
Kirsty Short
Following the 2009 H1N1 influenza virus pandemic, numerous studies identified a link between diabetes mellitus and severe influenza. Typically, influenza virus is a self-limiting infection. However, in individuals who have a pre-existing chronic illness, such as diabetes mellitus, severe disease can develop. Here, we discuss the latest clinical and experimental evidence for the role of diabetes in severe influenza infections. We explore the possible mechanisms that underlie this synergy and highlight the as yet unexplored role that blood glucose oscillations may play in disease development. Diabetes is one of the world’s fastest growing chronic diseases and influenza virus represents a constant and pervasive threat to human health. It is therefore imperative that we understand how diabetes increases influenza severity in order to mitigate the burden of future influenza epidemics and pandemics.

28 April 2020 in mBio
Verified
Journal Article
Open access
PDF file
RMRebecca J. Marshall
Rebecca J. Marshall
PAPornthida Armart
Pornthida Armart
KHKatina D. Hulme
Katina D. Hulme
KCKeng Yih Chew
Keng Yih Chew
ABAlexandra C. Brown
Alexandra C. Brown
Kirsty ShortKirsty Short
Kirsty Short
People with diabetes are two times more likely to die from influenza than people with no underlying medical condition. The mechanisms underlying this susceptibility are poorly understood. In healthy individuals, small and short-lived postprandial peaks in blood glucose levels occur. In diabetes mellitus, these fluctuations become greater and more frequent. This glycemic variability is associated with oxidative stress and hyperinflammation. However, the contribution of glycemic variability to the pathogenesis of influenza A virus (IAV) has not been explored. Here, we used an in vitro model of the pulmonary epithelial-endothelial barrier and novel murine models to investigate the role of glycemic variability in influenza severity. In vitro, a history of glycemic variability significantly increased influenza-driven cell death and destruction of the epithelial-endothelial barrier. In vivo, influenza virus-infected mice with a history of glycemic variability lost significantly more body weight than mice with constant blood glucose levels. This increased disease severity was associated with markers of oxidative stress and hyperinflammation both in vitro and in vivo. Together, these results provide the first indication that glycemic variability may help drive the increased risk of severe influenza in people with diabetes mellitus. IMPORTANCE Every winter, people with diabetes are at increased risk of severe influenza. At present, the mechanisms that cause this increased susceptibility are unclear. Here, we show that the fluctuations in blood glucose levels common in people with diabetes are associated with severe influenza. These data suggest that glycemic stability could become a greater clinical priority for patients with diabetes during outbreaks of influenza.

12 January 2024 in Cellular and Molecular Life Sciences
Verified
Journal Article
Open access
PDF file
KHKatina D. Hulme
Katina D. Hulme
ZTZhen Wei Marcus Tong
Zhen Wei Marcus Tong
LRLouise C. Rowntree
Louise C. Rowntree
CSCarolien E. van de Sandt
Carolien E. van de Sandt
KRKatharina Ronacher
Katharina Ronacher
Kirsty ShortKirsty Short
Kirsty Short
Diabetes mellitus is on the rise globally and is a known susceptibility factor for severe influenza virus infections. However, the mechanisms by which diabetes increases the severity of an influenza virus infection are yet to be fully defined. Diabetes mellitus is hallmarked by high glucose concentrations in the blood. We hypothesized that these high glucose concentrations affect the functionality of CD8+ T cells, which play a key role eliminating virus-infected cells and have been shown to decrease influenza disease severity. To study the effect of hyperglycemia on CD8+ T cell function, we stimulated peripheral blood mononuclear cells (PBMCs) from donors with and without diabetes with influenza A virus, anti-CD3/anti-CD28-coated beads, PMA and ionomycin (PMA/I), or an influenza viral peptide pool. After stimulation, cells were assessed for functionality [as defined by expression of IFN-γ, TNF-α, macrophage inflammatory protein (MIP)-1β, and lysosomal-associated membrane protein-1 (CD107a)] using flow cytometry. Our results showed that increasing HbA1c correlated with a reduction in TNF-α production by CD8+ T cells in response to influenza stimulation in a TCR-specific manner. This was not associated with any changes to CD8+ T cell subsets. We conclude that hyperglycemia impairs CD8+ T cell function to influenza virus infection, which may be linked with the increased risk of severe influenza in patients with diabetes.

22 July 2020 in eLife
Verified
Journal Article
Open access
KHKatina D Hulme
Katina D Hulme
LYLimin Yan
Limin Yan
RMRebecca J Marshall
Rebecca J Marshall
CBConor J Bloxham
Conor J Bloxham
KUKyle R Upton
Kyle R Upton
Kirsty ShortKirsty Short
Kirsty Short
Diabetes mellitus is a known susceptibility factor for severe influenza virus infections. However, the mechanisms that underlie this susceptibility remain incompletely understood. Here, the effects of high glucose levels on influenza severity were investigated using an in vitro model of the pulmonary epithelial-endothelial barrier as well as an in vivo murine model of type II diabetes. In vitro we show that high glucose conditions prior to IAV infection increased virus-induced barrier damage. This was associated with an increased pro-inflammatory response in endothelial cells and the subsequent damage of the epithelial junctional complex. These results were subsequently validated in vivo. This study provides the first evidence that hyperglycaemia may increase influenza severity by damaging the pulmonary epithelial-endothelial barrier and increasing pulmonary oedema. These data suggest that maintaining long-term glucose control in individuals with diabetes is paramount in reducing the morbidity and mortality associated with influenza virus infections.

4 April 2020 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
PDF file
JSJurre Y Siegers
Jurre Y Siegers
BNBoris Novakovic
Boris Novakovic
KHKatina D Hulme
Katina D Hulme
RMRebecca J Marshall
Rebecca J Marshall
CBConor J Bloxham
Conor J Bloxham
Kirsty ShortKirsty Short
Kirsty Short
Background: Influenza A virus (IAV) causes a wide range of extrarespiratory complications. However, the role of host factors in these complications of influenza virus infection remains to be defined.Methods: Here, we sought to use transcriptional profiling, virology, histology, and echocardiograms to investigate the role of a high-fat diet in IAV-associated cardiac damage.Results: Transcriptional profiling showed that, compared to their low-fat counterparts (LF mice), mice fed a high-fat diet (HF mice) had impairments in inflammatory signaling in the lung and heart after IAV infection. This was associated with increased viral titers in the heart, increased left ventricular mass, and thickening of the left ventricular wall in IAV-infected HF mice compared to both IAV-infected LF mice and uninfected HF mice. Retrospective analysis of clinical data revealed that cardiac complications were more common in patients with excess weight, an association which was significant in 2 out of 4 studies.Conclusions: Together, these data provide the first evidence that a high-fat diet may be a risk factor for the development of IAV-associated cardiovascular damage and emphasizes the need for further clinical research in this area.

16 February 2021 in eLife
Verified
Journal Article
Open access
KHKatina D Hulme
Katina D Hulme
Anjana KarawitaAnjana Karawita
Anjana Karawita
CPCassandra Pegg
Cassandra Pegg
MBMyrna Jm Bunte
Myrna Jm Bunte
HBHelle Bielefeldt-Ohmann
Helle Bielefeldt-Ohmann
Kirsty ShortKirsty Short
Kirsty Short
Influenza virus has a high mutation rate, such that within one host different viral variants can emerge. Evidence suggests that influenza virus variants are more prevalent in pregnant and/or obese individuals due to their impaired interferon response. We have recently shown that the non-allergic, paucigranulocytic subtype of asthma is associated with impaired type I interferon production. Here, we seek to address if this is associated with an increased emergence of influenza virus variants. Compared to controls, mice with paucigranulocytic asthma had increased disease severity and an increased emergence of influenza virus variants. Specifically, PB1 mutations exclusively detected in asthmatic mice were associated with increased polymerase activity. Furthermore, asthmatic host-derived virus led to increased disease severity in wild-type mice. Taken together, these data suggest that at least a subset of patients with asthma may be more susceptible to severe influenza and may be a possible source of new influenza virus variants.